This article was originally published in The Gray Sheet
Plans to submit a 510(k) for its EPOC 2000 blood-chemistry analyzer during the third quarter of 1993. The EPOC 2000 is a point-of-care diagnostic instrument that can perform multiple blood tests in under 10 minutes ("The Gray Sheet" Dec. 23, 1991, p. 5). The 510(k) filing will cover five tests, and the firm says that a second filing for a "full complement of tests" will take place following FDA clearance of the original 510(k). Abaxis recently revised the rotor of the EPOC 2000 to correct deficiencies seen with a prototype version of the device. The redesigned device can separate the patient's whole blood and measure the plasma sample with "the desired level of accuracy," the firm says.
You may also be interested in...
FDA action awaits Sun’s manufacturing facility in Halol after it failed to adequately address GMP deviations, though India’s top-ranked drug firm appears to have effectively lowered its dependence on the site that has had a patchy compliance run.
In a surprise to the market, Dr Reddy’s and Hikma have prevailed in challenging six method-of-use patents shielding Amarin’s Vascepa in the US, opening the door for a potential at-risk launch that would likely be challenged by the originator.
Duo will study up to four novel preclinical targets identified by Sitryx that may lead to potential new drugs for autoimmune diseases, which Lilly would then commercialize.